Ross L.

Ross L. is an experienced marketing professional with a strong background in the pharmaceutical and healthcare sectors. Currently serving as the Marketing Lead for Epilepsy & Rare Syndromes at UCB since 2022, Ross has previously held key marketing roles at Gilead Sciences, Pace Harmon, AAA, and Johnson & Johnson, with the latter two positions focused on marketing strategy and management. Ross has extensive experience at Abbott, where leadership in marketing and product management was recognized with notable awards. Educational credentials include an Executive Program for Senior Biotech & Life Sciences Leaders from Harvard Medical School and multiple advanced degrees from prestigious institutions, including UCLA Anderson School of Management and SDA Bocconi.